Related Experiment Videos

Release of adenylate kinase into cerebrospinal fluid during open-heart surgery and its relation to postoperative

PubMed

Insights

Open-heart surgery can cause brain cell injury, leading to elevated adenylate kinase (AK) levels in cerebrospinal fluid (CSF). Measuring CSF-AK may help improve surgical outcomes and patient brain health.

Area of Science:

  • Neurology
  • Biochemistry
  • Cardiovascular Surgery

Background:

  • Cardiopulmonary bypass during open-heart surgery is associated with potential neurological complications.
  • Biomarkers are needed to assess brain-cell injury during cardiac procedures.

Purpose of the Study:

  • To investigate the relationship between cardiopulmonary bypass and brain-cell injury.
  • To evaluate adenylate kinase (AK) levels in cerebrospinal fluid (CSF) as a potential indicator of neurological damage.

Main Methods:

  • Cerebrospinal fluid (CSF) adenylate kinase (AK) levels were measured in patients undergoing open-heart surgery.
  • CSF-AK levels were compared between patients with and without cardiopulmonary bypass.
  • Preoperative and postoperative CSF-AK levels were analyzed in a subset of patients.
  • Intellectual function was assessed and correlated with CSF-AK changes.

Main Results:

  • Elevated CSF-AK levels were observed in 33 out of 36 patients undergoing open-heart surgery.
  • No significant increase in CSF-AK was found in patients undergoing lung operations without cardiopulmonary bypass.
  • A significant increase in CSF-AK correlated with a decline in intellectual function.
  • No evidence of blood-brain barrier damage was detected.

Conclusions:

  • Cardiopulmonary bypass during open-heart surgery is linked to brain-cell injury.
  • Elevated CSF-AK levels indicate neurological damage.
  • CSF-AK measurement is a promising tool for research aimed at enhancing open-heart surgery quality.

Related Concept Videos